USPTO serial 85700753
APHESIS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GOODSAID, IRA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with APHESIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Katherine A. McGowan, Esq.
KATHERINE A. MCGOWAN, ESQ. FENWICK & WEST LLP801 CALIFORNIA STMOUNTAIN VIEW, CA 94041-1990UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | House mark for a full line of pharmaceuticals; pharmaceuticals for use in prevention, treatment and diagnosis of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders; pharmaceuticals for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation; pharmaceuticals for use in modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia, hormonal disorders, sexual dysfunction and infertility; preparations for detecting genetic predispositions for medical purposes | ACTIVE | — |
| 042 | Pharmaceutical and biotechnological research and development and product evaluation; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, laboratory testing, diagnostics and pharmacogenetics; genetic mapping and testing for scientific purposes; scientific research in the field of genetics and genetic engineering; medical and scientific research, namely, conducting clinical trials and evaluations in the field of new pharmaceuticals; development of new technology for others in the fields of genomics and biotechnology; research and development of technologies for the prevention, treatment and diagnosis of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders; research and development of technologies for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation; research and development of technologies for use in modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia, hormonal disorders, sexual dysfunction and infertility; biotechnology research, namely, pharmaceutical product research and development of drug therapies and diagnostic tests for the prevention and treatment of cardiovascular, autoimmune and neurological diseases, and for viral, cancer, nervous system, metabolic system, musculo-skeletal system, hematological, inflammatory, gastroenterological, respiratory and transplantation-related diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Strategicon Partners, LLC
- Other trademarks owned by Strategicon Partners, LLC
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named APHESIS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 14, 2014 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 14, 2014 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 28, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 26, 2013 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 26, 2013 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 26, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 12, 2013 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 15, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 15, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 26, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 7, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 7, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 14, 2012 | NWAP | NEW APPLICATION ENTERED | — |